Jodi A. Schwendimann, f/k/a Joda A. Dalvey and Nucoat, Inc. v. Neenah, Inc.

CourtDistrict Court, D. Delaware
DecidedJuly 9, 2026
Docket1:19-cv-00361
StatusUnknown

This text of Jodi A. Schwendimann, f/k/a Joda A. Dalvey and Nucoat, Inc. v. Neenah, Inc. (Jodi A. Schwendimann, f/k/a Joda A. Dalvey and Nucoat, Inc. v. Neenah, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jodi A. Schwendimann, f/k/a Joda A. Dalvey and Nucoat, Inc. v. Neenah, Inc., (D. Del. 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE JODI A. SCHWENDIMANN, f/k/a JODA A. DALVEY and NUCOAT, INC., Plaintiffs, v. Civil Action No. 19-361-GBW NEENAH, INC., Defendant.

MEMORANDUM ORDER Pending before the Court is a dispute between Plaintiffs Jodi A. Schwendimann f/k/a Joda A. Dalvey and Nucoat, Inc. (“Plaintiffs”) and Defendant Neenah, Inc. (“Defendant”) about the proper construction of the claim term “opaque background,” which appears in U.S. Patent No. 7,771,554 (the “’554 Patent”). See D.I. 415. Plaintiffs allege Defendant infringes claims 1-6 and 9-11 (“Asserted Claims”) of the °554 Patent. The Court held a Markman hearing on December 10, 2020. See D.I. 132. Before and during the Markman hearing, neither party requested construction of “opaque background.” The Court has carefully considered the parties’ briefing, the intrinsic and extrinsic evidence cited therein, and the record as a whole. D.I. 416; D.I. 417; D.I. 419; D.J. 420. Upon consideration of the full record, the Court issues the following construction of the disputed claim term.’ I. LEGAL STANDARD “Tt is a “bedrock principle’ of patent law that ‘the claims of a patent define the invention to which the patentee is entitled the right to exclude.’” Phillips v. AWH Corp., 415 F.3d 1303,

The Court writes for the benefit of the parties and assumes familiarity with the case.

1312 (Fed. Cir. 2005) (en banc) (quoting Innova/Pure Water, Inc. v. Safari Water Filtration Systems, Inc., 381 F.3d 1111, 1115 (Fed. Cir. 2004)); see also Corning Glass Works v. Sumitomo Elec. U.S.A., Inc., 868 F.2d 1251, 1257 (Fed. Cir. 1989) (“A claim in a patent provides the metes and bounds of the right which the patent confers on the patentee to exclude others from making, using, or selling the protected invention.”). “[T]Jhere is no magic formula or catechism for conducting claim construction.” Phillips, 415 F.3d at 1324. The Court is free to attach the appropriate weight to appropriate sources “in light of the statutes and policies that inform patent law.” Id. The ultimate question of the proper construction of a patent is a question of law, although subsidiary fact-finding is sometimes necessary. Teva Pharm. USA, Inc. v. Sandoz, Inc., 574 US. 318, 326 (2015); see also Markman vy. Westview Instruments, Inc., 517 U.S. 370, 378, 388-91 (1996). “The words of a claim are generally given their ordinary and customary meaning as understood by a person of ordinary skill in the art when read in the context of the specification and prosecution history.” Thorner v. Sony Comput. Ent. Am. LLC, 669 F.3d 1362, 1365 (Fed. Cir. 2012) (citing Phillips, 415 F.3d at 1313). A person of ordinary skill in the art “is deemed to read the claim term not only in the context of the particular claim in which the disputed term appears, but in the context of the entire patent, including the specification.” Phillips, 415 F.3d at 1313. “When construing claim terms, [the court] first look[s] to, and primarily rel[ies] on, the intrinsic evidence, including the claims themselves, the specification, and the prosecution history of the patent, which is usually dispositive.” Sunovion Pharms., Inc. v. Teva Pharms. USA, Inc., 731 F.3d 1271, 1276 (Fed. Cir. 2013). “Other claims of the patent in question, both asserted and unasserted, can . . . be valuable” in discerning the meaning of a disputed claim term, because “claim terms are normally used consistently throughout the patent” and so “the usage of a term in

one claim can often illuminate the meaning of the same term in other claims.” Phillips, 415 F.3d at 1314 (citing Rexnord Corp. v. Laitram Corp., 274 F.3d 1336, 1342 (Fed. Cir. 2001)). In addition, “[d]ifferences among claims can also be a useful guide in understanding the meaning of particular claim terms.” Jd. (citing Laitram Corp. v. Rexnord, Inc., 939 F.2d 1533, 1538 (Fed. Cir. 1991)). “For example, the presence of a dependent claim that adds a particular limitation gives rise to a presumption that the limitation in question is not present in the independent claim.” □□□ at 1314-15 (citing Liebel-Flarsheim Co. v. Medrad, Inc., 358 F.3d 898, 910 (Fed. Cir. 2004)). □

In addition to the claims, the court should analyze the specification, which “is always highly relevant to the claim construction analysis . . . [as] it is the single best guide to the meaning of a disputed term.” Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed. Cir. 1996). It is also possible that “the specification may reveal a special definition given to a claim term by the patentee that differs from the meaning it would otherwise possess. In such cases, the inventor’s lexicography governs.” Phillips, 415 F.3d at 1316 (citing CCS Fitness, Inc. v. Brunswick Corp., 288 F.3d 1359, 1366 (Fed. Cir. 2002)). “[E]ven when the specification describes only a single embodiment, [however,] the claims of the patent will not be read restrictively unless the patentee has demonstrated a clear intention to limit the claim scope using ‘words or expressions of manifest exclusion or restriction.”” Hill-Rom Servs., Inc. v. Stryker Corp., 755 F.3d 1367, 1372 (Fed. Cir. 2014) (quoting Liebel-Flarsheim, 358 F.3d at 906). Furthermore, the specification “is not a substitute for, nor can it be used to rewrite, the chosen claim language.” SuperGuide Corp. v. DirecTV Enters., Inc., 358 F.3d 870, 875 (Fed. Cir. 2004). The court “should also consider the patent’s prosecution history, if it is in evidence.” Markman vy. Westview Instruments, Inc., 52 F.3d 967, 980 (Fed. Cir. 1995), (citing Graham v. John Deere Co., 383 U.S. 1, 33 (1966)), aff'd, 517 U.S. 370 (1996). The prosecution history “can often

inform the meaning of the claim language by demonstrating how the inventor understood the invention and whether the inventor limited the invention in the course of prosecution □□□ □□ Phillips, 415 F.3d at 1317. In some cases, the court “will need to look beyond the patent’s intrinsic evidence and to consult extrinsic evidence in order to understand, for example, the background science or the meaning of a term in the relevant art during the relevant time period.” Teva, 574 U.S. at 331 (citing Seymour v. Osborne, 20 L.Ed. 33 (1871)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Seymour v. Osborne
78 U.S. 516 (Supreme Court, 1871)
Graham v. John Deere Co. of Kansas City
383 U.S. 1 (Supreme Court, 1966)
TIP Systems, LLC v. Phillips & Brooks/Gladwin, Inc.
529 F.3d 1364 (Federal Circuit, 2008)
Thorner v. Sony Computer Entertainment America LLC
669 F.3d 1362 (Federal Circuit, 2012)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Hill-Rom Services, Inc. v. Stryker Corporation
755 F.3d 1367 (Federal Circuit, 2014)
Aylus Networks, Inc. v. Apple Inc.
856 F.3d 1353 (Federal Circuit, 2017)
Prima Tek II, L.L.C. v. Polypap, S.A.R.L.
318 F.3d 1143 (Federal Circuit, 2003)
Superguide Corp. v. DirecTV Enterprises, Inc.
358 F.3d 870 (Federal Circuit, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Jodi A. Schwendimann, f/k/a Joda A. Dalvey and Nucoat, Inc. v. Neenah, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/jodi-a-schwendimann-fka-joda-a-dalvey-and-nucoat-inc-v-neenah-inc-ded-2026.